Edwards Lifesciences Corp (EW) · Insider Trading (Form 4) SEC Filing

=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-05-22 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: Edwards Lifesciences Corp (EW) CIK: 0001099800 --- Reporting Owner --- Name: Chopra Daveen CIK: 0001740963 Role: Officer (CVP, TMTT & Surgical) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-05-22 | Code: S (Open market sale) Shares: -1,500 | Price: $84.60 Total Value: $126,905.25 Shares Owned After: 44,324 | Ownership: D (Direct) Footnotes: [F1] This transaction was executed in multiple trades at prices ranging from $84.6002 to $84.6050. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. --- Footnotes (Complete Index) --- F1: This transaction was executed in multiple trades at prices ranging from $84.6002 to $84.6050. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. --- Signature --- /s/ Linda J. Park, Attorney-in-Fact (2026-05-22)